Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults
Publication
, Journal Article
Priddy, FH; Lewis, DJM; Gelderblom, HC; Hassanin, H; Streatfield, C; LaBranche, C; Hare, J; Cox, JH; Dally, L; Bendel, D; Montefiori, D ...
November 8, 2018
Duke Scholars
Publication Date
November 8, 2018
Citation
APA
Chicago
ICMJE
MLA
NLM
Priddy, F. H., Lewis, D. J. M., Gelderblom, H. C., Hassanin, H., Streatfield, C., LaBranche, C., … Johnson, P. (2018). Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults.
Priddy, Frances H., David J. M. Lewis, Huub C. Gelderblom, Hana Hassanin, Claire Streatfield, Celia LaBranche, Jonathan Hare, et al. “Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults,” November 8, 2018.
Priddy FH, Lewis DJM, Gelderblom HC, Hassanin H, Streatfield C, LaBranche C, et al. Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults. 2018 Nov 8;
Priddy, Frances H., et al. Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults. Nov. 2018.
Priddy FH, Lewis DJM, Gelderblom HC, Hassanin H, Streatfield C, LaBranche C, Hare J, Cox JH, Dally L, Bendel D, Montefiori D, Sayeed E, Ackland J, Gilmour J, Schnepp BC, Wright F, Johnson P. Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults. 2018 Nov 8;
Publication Date
November 8, 2018